Relationship of Nocturnal Melatonin Levels to Duration and Course of Multiple Sclerosis

References

• Adachi M., Volk B. W., Schneck L., Relkin R. Ultrastructural alterations of endocrine glands in Tay-Sachs' disease. American Journal of Clinical Pathology 1972; 57: 557–561
   PubMed Web of Science ®Google Scholar
• Adams R. D., Victor M. Principles of neurology 3rd Edition. McGraw-Hill, New York 1985; 699–717
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd edition. Washington, DC. 1987
   Google Scholar
• Angeli A., Gatti G., Sartori M. L., DelPonte D., Garagnola R. Effect of exogenous melatonin on human natural killer (NK) cell activity: an approach to the immunomodulatory role of the pineal gland. The pineal gland and cancer, D. Gupta, A. Attanasio, R. J. Reiter. Brain Research Promotion, London 1988
   Google Scholar
• Arendt J., Wirz-Justice A., Bradtke J., Kornemark M. Long-term studies on immuno-reactive human melatonin. Annals of Clinical Biochemistry 1979; 16: 307–312
   PubMed Web of Science ®Google Scholar
• Armstrong S. M., Redman J. R. Melatonin: a chronobiotic with anti-aging properties. Medical Hypotheses 1991; 34: 300–309
   PubMed Web of Science ®Google Scholar
• Bignami A., Gherardi D., Gallo G. Sclerosi a placche acuta a localizzazione ipotalamica con sintomatologia psichia di tipo malinconcio. Riv Neurologico 1961; 31: 240–268
   PubMedGoogle Scholar
• Blask D. E. The pineal: an oncostatic gland. The pineal gland, R. J. Reiter. Raven Press, New York 1984; 253–284
   Google Scholar
• Brownell B., Hughes J. T. The distribution of plaques in the cerebrum in multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry 1962; 25: 315–320
   PubMed Web of Science ®Google Scholar
• Cardarelli N. F. The role of a thymus-pineal axis in an immune mechanism of aging. Journal of Theoretical Biology 1990; 145: 397–405
   PubMed Web of Science ®Google Scholar
• Cassone V. M. Effects of melatonin on vertebrate circadian systems. Trends in Neurosciences 1990; 13: 457–464
   PubMed Web of Science ®Google Scholar
• Castaigne P., Escourelle R., Laplane D., Augustine P. Comas transitoires avec hyperth-ermie au cours de la sclerose en plaques. Encephale 1966; 55: 191–211
   PubMedGoogle Scholar
• Claustrat B., Brun J., Mallo C., Faure A., Zaidan R., Touitou Y., Chazot G. Melatonin in humans: methodological and ethical problems in clinical studies. Fundamentals and clinics in pineal research, G. P. Trentini, C. De Gaetani, P. Pevet. Raven Press, New York 1987; 321–328
   Google Scholar
• Cremieux A., Alliez J., Tonga M., Pache R. Sclerose en plaques a debut par troubles mentaux: Etude Anatomo-Clinique. Revue Neurologique (Paris) 1959; 101: 45–51
   PubMedGoogle Scholar
• Cunnane S. C., Manku M. S., Horrobin D. F. The pineal gland and regulation of fibrosis: pinealectomy as a model of primary biliary cirrhosis: roles of melatonin and prostaglandins in fibrosis and regulation of T lymphocytes. Medical Hypotheses 1979; 5: 403–407
   PubMed Web of Science ®Google Scholar
• Dafny N. Electrophysiological evidence of photic, acoustic, and central input to the pineal body and hypothalamus. Experimental Neurology 1977; 55: 449–457
   PubMed Web of Science ®Google Scholar
• Fanget F., Claustrat B., Dalery J., Brub J., Terra J. L., Marie-Cardine M., Guyotat J. Nocturnal plasma melatonin levels in schizophrenic patients. Biological Psychiatry 1989; 25: 499–501
   PubMed Web of Science ®Google Scholar
• Ferrier I. N., Arendt J., Johnstone E. C., Crow T. J. Reduced nocturnal melatonin secretion in chronic schiozphrenia: relationship to body weight. Clinical Endocrinology 1982; 17: 181–187
   PubMed Web of Science ®Google Scholar
• Hajdu S. I., Porro R. S., Lieberman P. H., Foote F. W. Degeneration of the pineal gland of patients with cancer. Cancer 1972; 29: 706–709
   PubMed Web of Science ®Google Scholar
• Jankovic B. D., Isakovic K., Petrovic S. Effect of pinealectomy on immune reactions in the rat. Immunology 1970; 18: 1–5
   PubMed Web of Science ®Google Scholar
• Juillard M. T., Collin J. P. Pools of serotonin in the pineal gland of the mouse: the mammalian pinealocyte as a component of the diffuse neuroendocrine system. Cell Tissue Research 1980; 213: 273–291
   PubMed Web of Science ®Google Scholar
• Kamalian N., Keesey R. E., Zu Rhein G. M. Lateral hypothalamic demyelination and cachexia in a case of “maligant” multiple sclerosis. Neurology 1975; 25: 25–30
   PubMed Web of Science ®Google Scholar
• Kamback D. O., Rich R. A., Relkin R. Effect of pinealectomy on fatty acid composition of rat brain myelin. Endocrinology. 1982; 110: 907–909
   PubMed Web of Science ®Google Scholar
• Kira J. I., Harada M., Yamaguchi Y., Shida N., Goto I. Hyperprolactinemia in multiple sclerosis. Journal of the Neurological Sciences 1991; 102: 61–66
   PubMed Web of Science ®Google Scholar
• Klein D. C., Weller J. L. Indole metabolism in the pineal gland: a circadian rhythm in N-acetyltrasferase. Science 1970; 169: 1093–1095
   PubMed Web of Science ®Google Scholar
• Kneisley L. W., Moskowitz M. A., Lynch H. J. Cervical spinal cord lesions disrupt the rhythm in human melatonin excretion. Journal of Neural Transmission 1978; 13: 311–323, (suppl)
   Google Scholar
• Lissoni P., Barni S., Tancini G., Crispino S., Paolorossi F., Cattaneo G., Lucini V., Mariani M., Esposti D., Esposti G., Fraschini F. Relation between lymphocyte subpopulations and pineal function in patients with early or metastatic cancer. Annals of the New York Academy of Sciences 1988; 52: 290–299
   Google Scholar
• Lumsden C. E. The neuropathology of multiple sclerosis and other demyelinating diseases. Handbook of clinical neurology, P. J. Vinken, G. W. Bruyn. North Holland, Amsterdam 1968; vol. 9: 217–309
   Google Scholar
• Maestroni G J. M., Conti A., Pierpaoli W. Role of the pineal gland in immunity. Circadian synthesis and release of melatonin modulates the antibody response and antagonizes the immunosuppressive effect of corticosterone. Journal of Neuroimmunology 1986; 13: 19–30
   PubMed Web of Science ®Google Scholar
• Maestroni G. J. M., Conti A., Pierpaoli W. The pineal gland and the circadian, opiatergic, immunoregulatory role of melatonin. Annals of the New York Academy of Science 1987a; 496: 67–77
   PubMed Web of Science ®Google Scholar
• Maestroni G. J. M., Conti A., Pierpaoli W. Melatonin counteracts the effect of acute stress on the immune system via an opiatergic system. Fundamentals and clinics in pineal research, G. P. Trentini, C. De Gaetani, P. Pevet. Raven Press, New York 1987h; vol. 44: 277–279
   Google Scholar
• Miles A., Philbrick D. R. S. Melatonin and psychiatry. Biological Psychiatry 1988; 23: 405–425
   PubMed Web of Science ®Google Scholar
• Monaco F., Fumero S., Mondino A., Mutani R. Plasma and cerebrospinal fluid tryptophan in multiple sclerosis and degenerative diseases. Journal of Neurology, Neurosurgery and Psychiatry 1979; 42: 640–641
   PubMed Web of Science ®Google Scholar
• Moore R. Y. Central neural control of circadian rhythms. Frontiers in neuroendocrinology, W. F. Ganong, L. Martin. Raven Press, New York 1978; 185
   Google Scholar
• Pirttila T., Antonen J., Syrjala P., Frey H. T-lymphocyte subpopulation levels and immunoglobulin changes in the cerebrospinal fluid of patients with neurologic disorders. Annals of the New York Academy of Sciences 1987; 496: 691–696
   PubMed Web of Science ®Google Scholar
• Poser C. M. Multiple sclerosis. Observations and reflections-a personal memoir. Journal of the Neurological Sciences 1992; 107: 127–140
   PubMed Web of Science ®Google Scholar
• Poser C. M., Paty D. W., Scheinberg L. New diagnostic criteria for multiple sclerosis; guidelines for research protocols. Annals of Neurology 1983; 13: 227–231
   PubMed Web of Science ®Google Scholar
• Prineas J. W. The etiology and pathogenesis of multiple sclerosis. Multiple sclerosis and other demyelinating diseases, P. J. Vinken, G. W. Bruyn. North Holland, Amsterdam 1970; 107–160
   Google Scholar
• Regelson W., Pierpaoli W. Melatonin: a rediscovered antitumor hormone. Its relation to surface receptor sex steroid metabolism. Immunologic response and chronobiologic factors in tumor growth and therapy. Cancer Investigation 1987; 5: 379–385
   PubMed Web of Science ®Google Scholar
• Reinherz E. L., Weiner H. L., Hauser S. L., Cohen J. A., Distaso J. A., Schlossman S. F. Loss of suppressor T-cells in active multiple sclerosis: analysis with monoclonal antibodies. New England Journal of Medicine 1980; 303: 125–129
   PubMed Web of Science ®Google Scholar
• Relkin R., Schneck L. Effects of pinealectomy on rat brain myelin. Proceedings of the Society for Experimental Biology and Medicine 1975; 148: 337–338
   PubMed Web of Science ®Google Scholar
• Relkin R., Fok W. Y., Schneck L. Pinealectomy and brain myelination. Endocrinology 1973; 92: 1426–1428
   PubMed Web of Science ®Google Scholar
• Rudick R. A. Helping patients live with multiple sclerosis. What primary care physicians can do. Postgraduate Medicine 1990; 88: 197–207
   PubMed Web of Science ®Google Scholar
• Sandyk R. Coexisting bipolar affective disorder and multiple sclerosis: The role of the pineal gland. International Journal of Neuroscience. 1991; 59: 267–270
   PubMed Web of Science ®Google Scholar
• Sandyk R. The pineal gland and multiple sclerosis. (Editorial). International Journal of Neuroscience 1992; 63: 206–215
   Web of Science ®Google Scholar
• Sandyk R. Treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience., in press
   Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. The pineal gland in multiple sclerosis. International Journal of Neuroscience 1991; 61: 61–67
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal plasma melatonin and alpha-melanocyte stimulating hormone levels during exacerbation of multiple sclerosis. International Journal of Neuroscience., in press a
   Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders. International Journal of Neuroscience., in press b
   Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal melatonin secretion in suicidal patients with multiple sclerosis. International Journal of Neuroscience., in press c
   Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Multiple sclerosis: relationship between seasonal variations of relapse and age of onset. International Journal of Neuroscience., in press d
   Google Scholar
• Sandyk R., Awerbuch G. I. Multiple sclerosis: The role of the pineal gland in its timing of onset and risk of psychiatric illness. International Journal of Neuroscience., in press e
   Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Pineal calcification and its relationship to the fatigue of multiple sclerosis. International Journal of Neuroscience., in press f
   Google Scholar
• Skegg D. C. G. Multiple sclerosis: nature or nurture. British Medical Journal 1991; 320: 247–248
   Google Scholar
• Tetsuo M., Markey S. P., Kopin I. J. Measurement of 6-hydroxymelatonin in human urine and its clinical variations. Life Sciences 1980; 27: 105–109
   PubMed Web of Science ®Google Scholar
• Zimmerman H. M., Netzky M. G. The pathology of multiple sclerosis. Research Publications of the Association for Research in Nervous and Mental Disease 1950; 28: 271–279
   PubMedGoogle Scholar